---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Guia de Bulas"
developer_entity: "Daniel Correia"
bundle_id: "com.danproductions.medical.guiadebulasf"
app_store_id: "1501094985"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Freemium"
offline_capable: true
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-08-16"
report_date: "2026-08-24"
last_verified: "2026-08-24T00:00:00.000Z"
report_version: "4.2.3"
total_reviews: 0
sentiment: "Thrilled"
sentiment_score: 90
confidence: "medium"
confidence_score: 0.45
top_praise_theme: "The application provides a simple and practical utility that benefits both students and professionals in the field"
review_sample_size: 2
total_review_count: 2
analyzed_review_count: 2
data_age_days: 2
momentum_velocity: "maintenance"
intelligence_version: 3
tags: ["medical", "freemium", "thrilled sentiment", "mobile app", "app review", "app analysis", "medical", "professionals,", "pharmacists,"]
canonical_url: "https://marlvel.ai/apps/guia-de-bulas"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Guia de Bulas Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Freemium
- **Signal**: Sentiment Thrilled
- **Recent focus**: The application provides a simple and practical utility that benefits both students and professionals in the field (top praise)

> **TL;DR:** Guia de Bulas is a medical app by Daniel Correia, with Thrilled user sentiment (90/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Guia de Bulas is a medical app by Daniel Correia.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **User Mood** | Thrilled |
| **Category** | Medical |
| **Developer** | Daniel Correia |
| **Pricing** | Freemium |
| **Platforms** | iOS & Android |
| **Confidence** | Medium (0.45/1.0) |
| **Data Age** | 2d |

## Metadata & Market Performance
- **Publisher:** Daniel Correia
- **Category:** Medical
- **Target Audience:** Medical professionals, pharmacists, nurses, and patients requiring quick, offline access to drug information.
- **Platforms:** iOS & Android
- **Version Reviewed:** 4.2.4
- **Report Date:** 2026-08-24
- **Signal Count:** 2 reviews analyzed
- **Confidence:** Medium (0.45/1.0)
- **App Store ID (iOS):** 1501094985
- **Bundle ID:** com.danproductions.medical.guiadebulasf
- **Google Play ID:** com.danproductions.medical.guiadebulasf
- **Performance Trend:** Stable
- **Data Window:** Analysis based on signals collected up to 2026-08-24
- **Short Description:** Complete drug information database, 100% offline.

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Guia de Bulas is a medical reference app for drug leaflets, designed for professionals and patients in Brazil with full offline functionality.
**Why users hire it:** The app removes the connectivity dependency inherent in web-based medical databases, allowing clinicians to access critical drug information in environments where network access is unreliable.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Offline Database:** Access to full drug information leaflets without an active internet connection.
  * *User Intent:* Users want uninterrupted access without internet dependency.
- **[Differentiator] Personalized Medication Notes:** User-defined annotations and dosage reminders attached to specific drug entries.
  * *User Intent:* Users value self-expression and personalized experiences.
- **[Standard] Advanced Search Filters:** Query medication database by brand name, generic name, or therapeutic indication.
  * *User Intent:* Users want to quickly find relevant content or features.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Guia de Bulas holds the #163 position in the Brazilian Medical category. The lack of a significant rating count across platforms suggests a reliance on organic search discovery rather than aggressive user acquisition.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Freemium
- **Tiers:** Free tier with ad support
- **Analysis:** The app utilizes an ad-supported model to monetize a free, offline-first utility for medical professionals and patients.

<!-- section:sentiment -->
## 🟢 User Sentiment (Medium Confidence: 2 of 2 reviews analyzed) {#user-sentiment}
- **Overall Sentiment:** Thrilled

### Top Praises
- **The application provides a simple and practical utility that benefits both students and professionals in the field**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Offline-first architecture removes connectivity dependencies
- Personalized note-taking creates professional switching costs

**Growth Levers:**
- Localized medical content expansion in Brazil
- Integration with digital prescription workflows


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The app has pivoted toward a localized Brazilian market strategy, with product development now prioritizing professional workflow utilities like Favorites sync over general UI updates.

**Overall trend**: Stable
**Compared at**: 2026-08-24

### High-impact changes
- **[Shifted] Professional Utility Focus** (features)

### Medium-impact changes
- **[Shifted] Localized Market Focus** (positioning)
- **[Shifted] Roadmap Priorities** (swot)

<!-- section:whats-new -->
## What's New

- **Latest (v4.2.4, 1 weeks ago):** General bug fixes and stability improvements.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Ships bug fixes at 53-day cadence.
- Latest release provides stability improvements.

> **Cadence:** 3 total versions · 0 majors in last 6 months · 7 days since last update · 53 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Guia de Bulas is a medical app that is free with in-app purchases.

<!-- speakable-start -->
> **Bottom Line:** Guia de Bulas succeeds by solving the connectivity friction inherent in clinical environments, but the maintenance-mode release cadence risks ceding ground to more active competitors. Prioritizing core utility sync would lock in the professional segment that currently relies on the offline-first advantage.
<!-- speakable-end -->

**Best for:** Medical professionals, pharmacists, nurses, and patients requiring quick, offline access to drug information.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Ship a Favorites sync feature because it is a top-requested utility for professionals → increase daily active habit
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Stable

The medical reference market is consolidating around apps that offer both offline reliability and rapid, automated drug-data updates. Guia de Bulas is currently advantaged by its offline-first architecture, but the lack of frequent updates threatens its long-term relevance for professionals who require current posology data.

- 🟢 Offline-first utility remains a strong differentiator in clinical settings where network access is unreliable, securing a core professional user base.
- 🔴 Maintenance-only update cadence (avg. 53 days) leaves the app vulnerable to competitors with faster drug-data refresh cycles, which erodes professional trust.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Sentiment | Thrilled (90/100) |
| Confidence | Medium |
| Pricing Model | Freemium |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Stable |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Guia de Bulas** (this app) | N/A/5 | Thrilled | Daniel Correia |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Daniel Correia
- **Website:** [https://www.alpenmob.com/](https://www.alpenmob.com/)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/guia-de-bulas/id1501094985?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.danproductions.medical.guiadebulasf)
- **Dev Site:** [Official Website](https://www.alpenmob.com/)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating
- [*1O Patient Portal*](https://marlvel.ai/apps/1o-patient-portal) (1st Optimal, LLC) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.45/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 2
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 2 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/guia-de-bulas)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.